Ramón V. Tiu

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

A. Jankowska, Hadrian Szpurka, Ramón V. Tiu et al. · Blood · 2009 · 378 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

Hideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi et al. · Blood · 2012 · 369 citations

Life Sciences, Genetics, Molecular Biology +14

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi et al. · The Lancet Haematology · 2017 · 330 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A

A. Jankowska, Hideki Makishima, Ramón V. Tiu et al. · Blood · 2011 · 321 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

Lukasz P. Gondek, Ramón V. Tiu, Christine L. O’Keefe et al. · Blood · 2007 · 309 citations · Full text

Life Sciences, Genetics, Hematology +17